VAERS Explorer
Back to explore

Report #2837668

Received Apr 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Furuncle

Symptom narrative

Boils; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of boil in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced boil (Verbatim: Boils). The outcome of the boil was not reported. It was unknown if the reporter considered the boil to be related to Shingrix. It was unknown if the company considered the boil to be related to Shingrix. Additional Information: GSK Receipt Date: 13-APR-2025 This case was reported by a patient via interactive digital media. The patient got the Shingrix vaccine and had boils The reporter asked can you develop boils after taken the vaccine. The case is 1 of the 6 linked case, by same reporter.; Sender's Comments: US-GSK-US2025AMR046237:same reporter US-GSK-US2025AMR046239:same reporter US-GSK-US2025AMR046242:same reporter US-GSK-US2025AMR046246:same reporter US-GSK-US2025AMR046250:same reporter